High doses of transplanted CD34+ cells are associated with rapid T-cell engraftment and lessened risk of graft rejection, but not more graft-versus-host disease after nonmyeloablative conditioning and unrelated hematopoietic cell transplantation.
- 浏览2

Leukemia
822-828页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文